EMEA AND FDA IDENTIFY PRIORITY TRANSATLANTIC MEDICINE REGULATORY PROJECTS
June 1st, 2008
BY KEITH NUTHALL
TRANSATLANTIC joint inspections of American, European Union (EU) and third country pharmaceutical plants are to be piloted by the European Commission, the European Medicines Agency (EMEA) and the US Food and Drug Administration (FDA). This was one of a series of priority projects to improve medicine regulatory cooperation between the European Union (EU) and the United States agreed at a meeting of the Transatlantic Economic Council (TEC) in Brussels. As regards third counties US and EU representatives agreed to jointly check standards at plants ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.